Targeted Therapy in Management of Advanced Follicular Thyroid Carcinoma

Authors

  • Leong Tung Ong Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia Author

DOI:

https://doi.org/10.47363/JNRRR/2020(2)116

Keywords:

Thyroid neoplasms, Molecular Targeted Therapy, Therapeutics

Abstract

Follicular thyroid carcinoma (FTC) is the second most common malignancy involving the thyroid glands. Early stages of FTC are managed with total thyroidectomy followed by 131I ablation and external beam radiation therapy. Targeted therapy with tyrosine kinase inhibitors (TKIs) is an essential therapeutic option for the management of advanced cases of radioactive iodine refractory. This review will investigate the clinical data for the therapeutic use of targeted therapy in advanced FTC and compare the efficacy of different targeted therapy used in managing the patients. 

Author Biography

  • Leong Tung Ong, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

    Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

Downloads

Published

2020-07-10

Issue

Vol. 2 No. 3 (2020): Volume 2 Issue 3

Section

Articles